Invasive Candidiasis

Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation

Non-Conventional Microbiological Methods in the Diagnosis of Candidemia

Pharmacokinetics of Micafungin in Patients of Intensive Care Units

Invasive Candidiasis in Critical Care

Comparison of Uncomplicated Candidemia Therapy Duration in Children

A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus

Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment

Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug

Early Discontinuation of Empirical Antifungal Therapy and Biomarkers

Evaluate Bioequivalence of Micafungin (50mg/Vial)

BIOPIC: Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric Candidemia

NOBICS - NOvel BIomarker In Invasive CandidiasiS/Candida Sepsis

Comparison of Two Diagnostic Tests in Patients With Suspected Invasive Candidiasis in Internal Medicine Wards and Who Are Currently Timely Treated With Micafungin

Genetic Susceptibility Factors for Candidemia.

CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension

Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive Aspergillosis

Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation

Invasive Candidiasis in Saudi ICUs

Variability of Fluconazole Concentration in Critically Ill Patients

Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067)